Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingeborg Zehbe

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Human Immunology|April 15, 2003
Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish womenIngeborg Zehbe, Joannis Mytilineos, Ingrid Wikström, et al.
International Journal of Health Promotion and Education|January 12, 2018
Engaging Canadian First Nations Women in Cervical Screening through EducationIngeborg Zehbe, Pamela Wakewich, Brianne Wood, et al.
Molecular Cancer|June 28, 2011
Rare human papillomavirus 16 E6 variants reveal significant oncogenic potentialIngeborg Zehbe, Hava Lichtig, Ashley Westerback, et al.
International Journal of Cancer|June 28, 2005
Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillanceIngeborg Zehbe, Hanni Höhn, Henryk Pilch, et al.
Plos One|December 11, 2012
Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytesMelissa Togtema, Samuel Pichardo, Robert Jackson, et al.
Plos Computational Biology|January 24, 2019
Epithelial stratification shapes infection dynamicsCarmen Lía Murall, Robert Jackson, Ingeborg Zehbe, et al.
Journal of Virological Methods|May 26, 2004
Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16Federica Gemignani, Stefano Landi, Amélie Chabrier, et al.
Antiviral Research|June 15, 2011
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesionsIngeborg Zehbe, Christina Richard, Kyle F Lee, et al.
Human Mutation|March 6, 2003
The role of TP53 in Cervical carcinogenesisMassimo Tommasino, Rosita Accardi, Sandra Caldeira, et al.
Clinical & Developmental Immunology|October 21, 2011
Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironmentCorrene A DeCarlo, Bruce Rosa, Robert Jackson, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Human Immunology|April 15, 2003
Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish womenIngeborg Zehbe, Joannis Mytilineos, Ingrid Wikström, et al.
International Journal of Health Promotion and Education|January 12, 2018
Engaging Canadian First Nations Women in Cervical Screening through EducationIngeborg Zehbe, Pamela Wakewich, Brianne Wood, et al.
Molecular Cancer|June 28, 2011
Rare human papillomavirus 16 E6 variants reveal significant oncogenic potentialIngeborg Zehbe, Hava Lichtig, Ashley Westerback, et al.
International Journal of Cancer|June 28, 2005
Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillanceIngeborg Zehbe, Hanni Höhn, Henryk Pilch, et al.
Plos One|December 11, 2012
Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytesMelissa Togtema, Samuel Pichardo, Robert Jackson, et al.
Plos Computational Biology|January 24, 2019
Epithelial stratification shapes infection dynamicsCarmen Lía Murall, Robert Jackson, Ingeborg Zehbe, et al.
Journal of Virological Methods|May 26, 2004
Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16Federica Gemignani, Stefano Landi, Amélie Chabrier, et al.
Antiviral Research|June 15, 2011
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesionsIngeborg Zehbe, Christina Richard, Kyle F Lee, et al.
Human Mutation|March 6, 2003
The role of TP53 in Cervical carcinogenesisMassimo Tommasino, Rosita Accardi, Sandra Caldeira, et al.
Clinical & Developmental Immunology|October 21, 2011
Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironmentCorrene A DeCarlo, Bruce Rosa, Robert Jackson, et al.
Pageof 6